10-Q: Diversified Healthcare Trust Reports Q2 2026 Results
Quarterly Report
Diversified Healthcare Trust's Q2 2026 filing reveals a net loss of $37.4 million, with total revenues down 4.5% year-over-year, though operational metrics show mixed performance across segments.
Summary
- Diversified Healthcare Trust (DHC) reported a net loss of $37.4 million for the three months ended June 30, 2026, compared to a net loss of $91.6 million in the same period last year.
- Total revenues for the quarter decreased by 4.5% to $365.4 million from $382.7 million in Q2 2025.
- The Senior Housing Operating Portfolio (SHOP) segment saw an increase in NOI by 46.1% to $53.5 million, driven by higher occupancy and average monthly rates.
- The Medical Office and Life Science Portfolio segment experienced a 10.5% decrease in NOI to $23.7 million, impacted by dispositions and increased operating expenses.
- General and administrative expenses increased significantly due to estimated incentive management fees recognized for the period.
- The company had $116.8 million in cash and cash equivalents as of June 30, 2026, with $150 million available under its revolving credit facility.
Sentiment
Score: 4
Explanation: StockSavvy.ai views this filing as slightly negative due to the continued net loss and decrease in total revenues, despite some operational improvements in specific segments.
Positives
- The Senior Housing Operating Portfolio (SHOP) segment showed strong performance with a 37.2% increase in NOI for comparable properties, driven by higher occupancy (83.1% vs 81.5%) and average monthly rates ($5,715 vs $5,380).
- The company's credit rating was upgraded by Moody's, with the issuer credit rating moving from Caa1 to B3 and the outlook to positive.
- Total revenues for the SHOP segment increased by 6.6% at comparable properties.
- The Medical Office and Life Science Portfolio segment saw a slight increase in rental income of 0.5% at comparable properties.
- The company reported compliance with its debt covenants as of June 30, 2026.
- Cash provided by operating activities was $46.7 million for the six months ended June 30, 2026.
Negatives
- The company reported a net loss of $37.4 million for the three months ended June 30, 2026, and $80.7 million for the six months ended June 30, 2026.
- Total revenues decreased by 4.5% to $365.4 million for the three months ended June 30, 2026, and by 4.9% to $731.9 million for the six months ended June 30, 2026.
- The Medical Office and Life Science Portfolio segment's NOI decreased by 10.5% for comparable properties.
- General and administrative expenses increased by 73.0% for the three months ended June 30, 2026, largely due to incentive management fees.
- Property operating expenses increased at comparable SHOP properties by 1.9% for the three months and 2.6% for the six months, driven by labor and insurance costs.
- The company incurred $30.993 million in impairment of assets during the three months ended June 30, 2026, and $69.465 million for the six months ended June 30, 2025.
Risks
- Unfavorable market and commercial real estate industry conditions due to possible reduced demand for healthcare-related space and senior living communities, uncertainties surrounding interest rates, wage and commodity price inflation, supply chain disruptions, volatility in the public debt and equity markets, geopolitical instability and tensions, pandemics, economic downturns or a possible recession, labor market conditions or changes in real estate utilization.
- The financial strength of managers, operators, and tenants, and their ability to pay amounts owed.
- Risks and uncertainties regarding the costs and timing of development, redevelopment and repositioning activities, including as a result of inflation, cost overruns, labor shortages, and construction delays.
- The ability to manage capital expenditures and operating costs effectively.
- Potential conflicts of interest with related parties, including managing trustees and RMR.
- Limitations imposed by and the ability to satisfy complex rules to maintain REIT qualification.
- Exposure to litigation and regulatory and government proceedings due to the nature of the businesses.
Future Outlook
The company expects favorable supply and demand dynamics in the senior living industry to enable managers to continue growing occupancy and driving positive performance. While certain costs have increased, moderation is expected, allowing for revenue increases to outpace cost increases. The company is reviewing underperforming communities for potential disposition or transition to different operators.
Management Comments
- We are encouraged by positive trends, including increases in rates, margins and occupancy in our SHOP segment.
- Additionally, we expect that favorable supply and demand dynamics in the senior living industry will enable our managers to continue to grow occupancy and drive positive performance.
- While certain costs, primarily labor, insurance and food costs, have increased, we expect these cost increases to moderate, which will provide our managers the opportunity to increase revenue in excess of increases in costs, resulting in improving returns to us.
- In an effort to optimize performance, our asset management team reviews the results of each of our senior living communities and our operators, taking into account various factors such as performance metric benchmarks, location and other relevant data points.
- As a result of these reviews, our strategy to drive positive performance includes analyzing non-performing communities for potential disposition or transition to different operators.
Industry Context
StockSavvy.ai notes that the company's performance in the Senior Housing Operating Portfolio (SHOP) segment aligns with broader industry trends of recovering occupancy and increasing rates, driven by favorable demographics. However, the Medical Office and Life Science segment faces headwinds from dispositions and rising operating costs, reflecting a more challenging sub-sector within healthcare real estate.
Comparison to Industry Standards
- The SHOP segment's occupancy rate of 82.5% for all properties and 83.1% for comparable properties is an improvement over the prior year, indicating a recovery trend in senior living, though it may still lag behind pre-pandemic levels or top-performing peers.
- The average monthly rate increase in the SHOP segment reflects inflationary pressures and increased demand, a trend observed across the senior living industry.
- The Medical Office and Life Science Portfolio's occupancy rate of 92.2% for all properties and 95.8% for comparable properties is strong, generally in line with or exceeding industry benchmarks for well-located medical office buildings, but the decline in NOI suggests operational challenges or lease expirations impacting revenue.
- The weighted average remaining lease term of 4.7 years for the Medical Office and Life Science Portfolio's expiring leases in 2026 and thereafter indicates a need for proactive leasing strategies to maintain occupancy and rental income, a common challenge in this sector.
- The company's FFO per share of $0.16 for the quarter is a key metric for REITs, and its comparison to peers would require further analysis of their respective FFO calculations and portfolio compositions.
Legal Proceedings
- The company is involved in claims, lawsuits, and regulatory and other governmental audits, investigations, and proceedings arising in the ordinary course of business. Management does not believe any currently pending litigation or proceedings will have a material adverse effect on its financial condition, results of operations, or cash flows.
Related Party Transactions
- The company has ongoing transactions with RMR, RMR Inc., and related entities, including business management fees, property management fees, and expense reimbursements.
- Adam D. Portnoy, Chair of the Board, is a controlling shareholder of RMR Inc. and an officer/employee of RMR.
- Christopher J. Bilotto, President and CEO, is an executive of RMR Inc.
- Matthew C. Brown, CFO and Treasurer, is an executive vice president and CFO/Treasurer of RMR Inc.
- The company leases office space to RMR.
- AlerisLife, in which the company previously held a significant stake, has wound down its business, with related dividend payments impacting the company's investment carrying value.
Stakeholder Impact
- Shareholders: Continued net losses and a decrease in total revenues may impact investor sentiment and stock price. However, the positive trend in SHOP segment NOI and the credit rating upgrade could be viewed positively.
- Creditors: The company's compliance with debt covenants and available liquidity are positive for creditors. However, ongoing economic uncertainties could pose future risks.
- Employees: Not directly addressed in the filing, but operational performance and management decisions could indirectly impact employment at managed communities.
- Suppliers: Increased operating expenses, particularly for labor and insurance, may impact supplier costs and relationships.
Next Steps
- Continue to review underperforming communities for potential disposition or transition to different operators.
- Monitor impacts of economic and market conditions, including interest rates, inflation, and geopolitical events.
- Manage capital expenditures and potential redevelopment projects, with a possibility of deferring projects to preserve liquidity.
- Continue to manage interest rate risk through monitoring financing alternatives and derivative instruments.
Key Dates
| Date | Description |
|---|---|
| 2025-12-31 | Balance sheet date |
| 2026-01-01 | Start of six-month period for financial statements |
| 2026-01-09 | AlerisLife paid aggregate cash dividend |
| 2026-03-31 | Balance sheet date |
| 2026-04-01 | Start of three-month period for financial statements |
| 2026-06-30 | Quarterly period end date for financial statements |
| 2026-07-09 | Declaration of quarterly distribution |
| 2026-08-13 | Expected payment date for quarterly distribution |
Recommendation
holdThe company shows mixed results with a significant improvement in the SHOP segment's operational performance (NOI) and a credit rating upgrade, which are positive indicators. However, the continued net loss, decrease in overall revenues, and increased general and administrative expenses due to incentive fees present significant concerns. The company's outlook is cautiously optimistic due to industry trends in senior living, but economic uncertainties and operational cost pressures remain. Therefore, a 'hold' recommendation is appropriate, pending further evidence of sustained profitability and revenue growth across all segments.
Keywords
Senior Housing, Medical Office, Life Science, REIT, Real Estate, Occupancy, Rental Income, NOI
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.